Integria Healthcare (Australia) Pty Ltd. (Integria Healthcare (Australia) Pty Ltd.)

概览

关联

11

项与 Integria Healthcare (Australia) Pty Ltd. 相关的临床试验

ACTRN12624000276550

/ Recruiting临床1期

Safety and efficacy of Eucalypt sap resin for inflammatory skin conditions and wound care in adults – An exploratory case series

开始日期2024-04-24

申办/合作机构

Integria Healthcare (Australia) Pty Ltd.

ACTRN12624000204549

/ Not yet recruiting临床2期

Pilot oral safety and efficacy of eucalypt sap resin for the management of recurrent vulvovaginal candidiasis (RVVC) and associated gastrointestinal symptoms: A comparative, 2-arm, double-blinded randomised study

开始日期2024-03-11

申办/合作机构

Integria Healthcare (Australia) Pty Ltd.

ACTRN12623000287639

/ Suspended临床2期

A randomised placebo-controlled trial investigating effectiveness of two herbal combinations for short-term stress management in healthy adults

开始日期2023-04-17

申办/合作机构

Integria Healthcare (Australia) Pty Ltd.

100 项与 Integria Healthcare (Australia) Pty Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Integria Healthcare (Australia) Pty Ltd. 相关的专利（医药）

登录后查看更多信息

1

项与 Integria Healthcare (Australia) Pty Ltd. 相关的文献（医药）

Chemical science1区 · 化学

Biosynthetic insights provided by unusual sesterterpenes from the medicinal herb Aletris farinosa

1区 · 化学

ArticleOA

作者: Challinor, Victoria L. ; Bernhardt, Paul V. ; Johnston, Ryne C. ; Krenske, Elizabeth H. ; Lehmann, Reginald P. ; De Voss, James J.

Configuration of a single stereocenter determines if a key carbocation in sesterterpene biosynthesis undergoes simple elimination or a cascade of seven 1,2-methyl and hydride migrations.

100 项与 Integria Healthcare (Australia) Pty Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Integria Healthcare (Australia) Pty Ltd. 相关的转化医学

登录后查看更多信息